AIDS vaccine models: challenging challenge viruses (Q77719659)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

AIDS vaccine models: challenging challenge viruses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Mark B Feinberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

John P Moore

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

207-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Vaccines for the prevention of HIV-1 disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection--evidence for highly susceptible human hosts

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Human immunodeficiency virus infection and AIDS in a person with negative serology

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

The dynamics of CD4+ T-cell depletion in HIV disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

The mucosal immune system: primary target for HIV infection and AIDS.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Control of SIV rebound through structured treatment interruptions during early infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

The infiltration kinetics of simian immunodeficiency virus-specific T cells drawn to sites of high antigenic stimulation determines local in vivo viral escape.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM0302-207

7 January 2021

Identifiers

DOI

10.1038/NM0302-207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11875482%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference